Skip to main content

Topic

Premarket Approval

34 published works

  1. Regulatory Oversight

    Tobacco Manufacturers and Retailers Sue the FDA Over Its Premarket Review Rule

    By Bryan Haynes, Nick Ramos

    On September 2, 2026, a group of tobacco product manufacturers and retailers filed a complaint in federal court, the U.S. District Court for the Northern District of Texas, challenging the…

  2. Clark-Esposito Law Firm, P.C.

    FDA Roundtable on ENDS PMTAs: More Clarity, Still No Clear Target

    By Clarkespositolaw

    At its February 10, 2026 ENDS PMTA roundtable, FDA stressed that complete product data, strong manufacturing controls, and solid scientific evidence, especially for flavored products, are critical for authorization. While…

  3. Tobacco Law Blog

    Court Rules That Ohio AG Cannot Enforce FDA Premarket Authorization Requirements

    By Bryan Haynes, Nick Ramos

    An Ohio appellate court recently affirmed the dismissal of a case brought by the Ohio attorney general (AG) against Central Tobacco & Stuff Inc. (Central Tobacco), an e-cigarette retailer, in…

  4. Drug & Device Law

    No Cause of Action for Robbing the FDA of an Opportunity

    By Michelle Yeary

    If you’re a frequent visitor to the DDL blog, you’ll know all about products liability claims premised on defendants’ alleged failure to report adverse events to the FDA.  You’ll also…

  5. Drug & Device Law

    PMA Preemption of Manufacturing Defect Claim: Long Time Coming

    By Stephen McConnell

    Federal preemption of tort claims involving medical devices receiving premarket approval (PMA) is a powerful defense. But for some reason, there are plaintiff lawyers who think it does not apply,…

  6. Health Care and Life Sciences

    FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company

    By Dominick DiSabatino, Cortney Inman

    On May 21, 2024, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) published a warning letter issued to Akan Biosciences, Inc. (Akan)…

  7. Regulatory Oversight

    Inside FDA’s Response to Reagan-Udall Foundation Report: Spotlight on the Science and Application Review Task Force

    By Michael Jordan, Agustin Rodriguez, Bryan Haynes

    This is the second post in our multipart series evaluating the Food and Drug Administration's response to the Regan-Udall Foundation report on the operations of the Center for Tobacco Products.…

  8. The Continuum of Risk

    FDA Files Civil Money Penalty Complaints Against Four Small Vape Shops for Alleged Premarket Review Violations

    By Azim Chowdhury, Ian Murray

    On February 22, 2023, the U.S. Food and Drug Administration (FDA) announced the filing of civil money penalty (CMP) complaints against four domestic e-liquid manufacturers, all of which appear to…

  9. The Continuum of Risk

    Partner Azim Chowdhury Authors Article on the Flaws of the Tobacco Control Act’s Premarket Authorization Requirement for New Tobacco Products in Filter

    By Keller and Heckman LLP

    Keller and Heckman Partner Azim Chowdhury authored the Filter article, “Fundamental Flaws of Tobacco Control Act—and FDA’s Implementation,” published on November 14, 2022. The article discusses the Tobacco Control Act, passed by…

  10. The Continuum of Risk

    FDA Files Permanent Injunctions Against Six Small Vape Shops for Alleged Premarket Review Violations

    By Azim Chowdhury, Ian Murray

    On October 18, 2022, the U.S. Department of Justice (DOJ), on behalf of the U.S. Food and Drug Administration (FDA), filed complaints for permanent injunctions against six domestic e-liquid manufacturers…